JANE STREET GROUP, LLC - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRW and the CUSIP is G3141W122. A total of 27 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q1 2023$970
-35.9%
26,838
-1.4%
0.00%
Q4 2022$1,513
+51.3%
27,218
+1.5%
0.00%
Q3 2022$1,000
-50.0%
26,813
-3.1%
0.00%
Q2 2022$2,000
-60.0%
27,670
+4.0%
0.00%
Q1 2022$5,000
-66.7%
26,611
+0.0%
0.00%
Q4 2021$15,000
-21.1%
26,600
-0.2%
0.00%
Q3 2021$19,000
-32.1%
26,640
+0.2%
0.00%
Q2 2021$28,000
-15.2%
26,6000.0%0.00%
Q1 2021$33,00026,6000.00%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q4 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 66,666$675,9930.02%
Arena Investors LP 94,516$3,4500.00%
Altium Capital Management LP 133,333$4,8200.00%
COWEN AND COMPANY, LLC 202,371$8,1960.00%
683 Capital Management, LLC 196,348$7,9520.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Radcliffe Capital Management, L.P. 33,333$1,2050.00%
PRICE T ROWE ASSOCIATES INC /MD/ 22,697$10.00%
KINGDON CAPITAL MANAGEMENT, L.L.C. 66,665$2,2000.00%
MORGAN STANLEY 1,300$430.00%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders